{"name":"Vico Therapeutics B. V.","slug":"vico-therapeutics-b-v","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMimwJBVV95cUxQWGlBMGl1cmlOSFlFNHdkR1JfU2FUQ0d0SmtzRmtpRy0waGtBTlRtU19SemNfUHZRc2hHYVNwUFZVOThpamxYemVldmlhRDdzTE0ydGptX3drNm4tQ0tMeGlLR1gzeVY5bzlmWVl3Q3lWalhjNkd2a2RIUmYyVmFRUWI4bkl2WnB1dnJyYlJONWZqV3ZkQjRWVklsOENXN1BWQkQyaHJxRWw2bGQ3SG1vQWU0bk1wWXBaWVBIMHRTOGpSRHBJU0ZkYTZ4YXN2RUpSMkUwWnJMSkhlR2tERGl6SjFCN2xZTnlaZVRRSzZIVVhMWHB0OW9lMWJkeTdDaDRtUTl6ejFjcFlRUTk3NEdWMElmTWVuSm1uNGVN?oc=5","date":"2024-06-24","type":"deal","source":"businesswire.com","summary":"Seroba and Kurma Partners Announce Complementary Series B Funding for Vico Therapeutics totaling €65.8 million ($70.7 million) - businesswire.com","headline":"Seroba and Kurma Partners Announce Complementary Series B Funding for Vico Therapeutics totaling €65.8 million ($70.7 mi","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuwJBVV95cUxNRGFfdnZYSEpNdXY0UkdjVXdLZkc2NFZyQUpMcmlCM3lZdndydUxCWGhWd0ZGU1kzMnc5TF92TFVZOTVhRGNHVFBMUTlTS2R2VjlKTWlBSHVLdThTNFlVcGNyaV80MlZsODhZTnhhVDIwME1CYWY3Q1ZvMm9PNTNFR01rRGpXNEI5QVh4a3JURkY1VklMYTBUQjNEUUN0Ylc4SkRIeTdGanRIdWVrRU5PNUxVMFJESUlxOXc1Tng2QU5laFo1V2ludVJ4cmRpckt5elVmNXVqdGRLZnB1VzBFSlhFRnlfdGlOS3lYWXlvcWVLeHR2Wm42NVZRbGhTWE1vSFpmUFk1bDNKMmNVblVrS3Nkd21tLUF3Smp5RjU0UWI3dzZDeHJHT21nNHhxR0ZhaUlQbmlkektXMzg?oc=5","date":"2024-01-05","type":"pipeline","source":"prnewswire.com","summary":"Vico Therapeutics Announces $60 million (€54 million) Series B Financing to Advance VO659 Clinical-Stage Program for Rare Neurological Diseases and Expand Pipeline - prnewswire.com","headline":"Vico Therapeutics Announces $60 million (€54 million) Series B Financing to Advance VO659 Clinical-Stage Program for Rar","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwgFBVV95cUxNejFIUkk0WW1qTlBXN1lUMnVRNUxYVGxMYURSMXZRVjNMMHlPcU1UN2lQNVhwNlNPYlhGb2lXREpac0pVRlIxOFlJbkRDQV9zdmNBdkNLS2VuQ29kcHhfa3N6bjVSZEpPaFdSbENsSk1PdU9MSk9uVXpkMk1iX2Ffc1lTMTREVkpudUZPdkpaNVFsRjRXLTZtQ3E3cGVpbm5UM3NmR1pVMnAtcjI2U3FsbG01Zk1nclh5ZEpORzFFUkVHZw?oc=5","date":"2022-08-01","type":"pipeline","source":"prnewswire.com","summary":"Vico Therapeutics Appoints Micah Mackison as Chief Executive Officer - prnewswire.com","headline":"Vico Therapeutics Appoints Micah Mackison as Chief Executive Officer","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimwFBVV95cUxNdTBEenlFTE8xWkdKYnFwX2Z6Z3NVdWFvMURNZzdUV0N1R0Q4N0lQeW5wUHM0bnRsWk1laS1nTFFEcDBsR1NFbUJSemExb0pZM3dqalhVbXhneVE0Y3BTemtUVFhwZnN4WDNUdDhNbEo5d0J3Y2EtbkFHZDFaOHNmWi01NlhaN3RTVDQxMXZMSXpnanRBb0ZkVWhBWQ?oc=5","date":"2021-06-14","type":"pipeline","source":"EU-Startups","summary":"87 Top Health Care Startups and Companies in The Netherlands (2021) - EU-Startups","headline":"87 Top Health Care Startups and Companies in The Netherlands (2021) - EU","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigAFBVV95cUxNNVdNanhvTFdlaGZCZk9zNUNja08wTmdtd3l3TV9TSmNLQngxRVp2WWNQVlM2WnJrS255dTcyNjFuSXFZcVRrQ0JZQlRCYnFYQXczY2o5aDlZQ0JXOHEzaG9vYV9RaXFXdEtCLTFMYjhCeVR1T0Nxcno3YjJjMWhXYw?oc=5","date":"2021-05-10","type":"pipeline","source":"channeleye.media","summary":"Pureos Bioventures supported on debut fund launch by Carey Olsen and Northern Trust - channeleye.media","headline":"Pureos Bioventures supported on debut fund launch by Carey Olsen and Northern Trust","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuwJBVV95cUxPcEpDRVF4VUJVSnBDTF9PTGM4dXFmd0R3aTdGdkdlZy0tTFBsNE1heEVpU2JYVTVPMTZuUmFBemlWX29rNjNMSnp0cjFGYjFpVVN0QmRDVEZVbUFCU3dvOTl2a0QtUDcwZnlEend4S0pRLWRxSjZHbkpTQUVfdlZIZHI2ZjA0TUdHZm9NS1JVV29scS1xLTRMQ2EzbnlLZUdycTlxRk1zMVd3SElNakJSbUZWQ1RvanljLXk3QTlJUHUxNUxIWmxSMTc2NzRQNm5sSTljOFFrVFRiR3FXRHdxS2pFM1pXRjdQQUxZdm1lbUR4cVJpRWt3b3ZjNGE0N3BNUi1WaUZuODZmNk52UkM4cG1qRkJXNW1OQnZIN1c1ZFJiR25EQ2VxMFZmTUxBOUgzLXV0MDIwTjNucWc?oc=5","date":"2020-10-01","type":"pipeline","source":"prnewswire.com","summary":"Dutch Vico Therapeutics strengthens leadership team with the appointment of Rupert Sandbrink as Chief Medical Officer and Anders Hinsby as Independent Director - prnewswire.com","headline":"Dutch Vico Therapeutics strengthens leadership team with the appointment of Rupert Sandbrink as Chief Medical Officer an","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}